Intra Cellular Therapies reported $61.54M in Trade Debtors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US USD 56.14M 12.75M
ALKERMES ALKS:US USD 267.28M 4.95M
Biocryst Pharmaceuticals BCRX:US USD 42.61M 1.12M
Biogen BIIB:US USD 1.98B 19.3M
Bristol Myers Squibb BMY:US USD 13.24B 700M
Cytokinetics CYTK:US USD 2.29M 321K
Esperion Therapeutics ESPR:US USD 31.49M 3.64M
Gilead Sciences GILD:US USD 4.35B 236M
Halozyme Therapeutics HALO:US USD 233.3M 43.93M
Intra Cellular Therapies ITCI:US USD 61.54M 14.56M
JAZZ PHA JAZZ:US USD 601.18M 7.14M
Marinus Pharmaceuticals MRNS:US USD 3.4M 398K
Nektar Therapeutics NKTR:US USD 11.53M 1.53M
Neurocrine Biosciences NBIX:US USD 301.2M 22.2M
Novartis NVS:US USD 8.68B 230M
Supernus Pharmaceuticals SUPN:US USD 164.09M 6.02M
United Therapeutics UTHR:US USD 231.7M 58.3M
Vanda Pharmaceuticals VNDA:US USD 29.35M 547K